{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:39:16Z","timestamp":1790836756305,"version":"4.1.0"},"reference-count":149,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T00:00:00Z","timestamp":1566777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T00:00:00Z","timestamp":1566777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s12328-019-01037-y","type":"journal-article","created":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T08:02:57Z","timestamp":1566806577000},"page":"139-152","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Relationship(s) between obesity and inflammatory bowel diseases: possible intertwined pathogenic mechanisms"],"prefix":"10.1007","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6569-8495","authenticated-orcid":false,"given":"Andrew","family":"Szilagyi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,26]]},"reference":[{"key":"1037_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.autrev.2004.03.002","volume":"3","author":"S Danese","year":"2004","unstructured":"Danese S, Sans M, Fiocchi C. Inflammatory bowel disease: the role of environmental factors. Autoimmun Rev. 2004;3:394\u2013400.","journal-title":"Autoimmun Rev"},{"key":"1037_CR2","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.mayocp.2018.09.013","volume":"94","author":"GP Ramos","year":"2019","unstructured":"Ramos GP, Papadakis KA. Mechanisms of disease: inflammatory bowel diseases. Mayo Clin Proc. 2019;94:155\u201365.","journal-title":"Mayo Clin Proc"},{"key":"1037_CR3","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","volume":"390","author":"SC Ng","year":"2018","unstructured":"Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2018;390:2769\u201378.","journal-title":"Lancet"},{"key":"1037_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1753-4887.2011.00456.x","volume":"70","author":"BM Popkin","year":"2012","unstructured":"Popkin BM, Adair LS, Ng SW. Global nutrition transition and the pandemic of obesity in developing countries. Nutr Rev. 2012;70:3\u201321.","journal-title":"Nutr Rev"},{"key":"1037_CR5","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1093\/qjmed\/hcx152","volume":"111","author":"D Kinlen","year":"2017","unstructured":"Kinlen D, Cody D, O\u2019Shea D. Complications of obesity. QJM. 2017;111:437\u201343.","journal-title":"QJM"},{"key":"1037_CR6","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.ccl.2004.06.005","volume":"22","author":"GA Mensah","year":"2004","unstructured":"Mensah GA, Mokdad AH, Ford E, et al. Obesity, metabolic syndrome, and type 2 diabetes: emerging epidemics and their cardiovascular implications. Cardiol Clin. 2004;22:485\u2013504.","journal-title":"Cardiol Clin"},{"key":"1037_CR7","doi-asserted-by":"publisher","first-page":"865965","DOI":"10.1155\/2013\/865965","volume":"2013","author":"MP Canale","year":"2013","unstructured":"Canale MP, Manca di Villahermosa S, Martino G, et al. Obesity-related metabolic syndrome: mechanisms of sympathetic overactivity. Int J Endocrinol. 2013;2013:865965.","journal-title":"Int J Endocrinol"},{"issue":"12","key":"1037_CR8","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1097\/00042737-200012120-00015","volume":"12","author":"S Erlinger","year":"2000","unstructured":"Erlinger S. Gallstones in obesity and weight loss. Eur J Gastroenterol Hepatol. 2000;12(12):1347\u201352.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1037_CR9","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1056\/NEJMsr1606602","volume":"375","author":"B Lauby-Secretan","year":"2016","unstructured":"Lauby-Secretan B, Scoccianti C, Loomis D, et al. Body fatness and cancer\u2013viewpoint of the IARC working group. N Engl J Med. 2016;375:794\u20138.","journal-title":"N Engl J Med"},{"issue":"313\u2013321","key":"1037_CR10","first-page":"e2","volume":"152","author":"GG Kaplan","year":"2017","unstructured":"Kaplan GG, Ng SC. Understanding and preventing the global increase of inflammatory bowel disease. Gastroenterology. 2017;152(313\u2013321):e2.","journal-title":"Gastroenterology"},{"key":"1037_CR11","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1056\/NEJMp068177","volume":"356","author":"P Hossain","year":"2007","unstructured":"Hossain P, Kawar B, El Nahas M. Obesity and diabetes in the developing world-a growing challenge. N Engl J Med. 2007;356:213\u20135.","journal-title":"N Engl J Med"},{"key":"1037_CR12","doi-asserted-by":"publisher","first-page":"7868","DOI":"10.3748\/wjg.v22.i35.7868","volume":"22","author":"JW Harper","year":"2016","unstructured":"Harper JW, Zisman TL. Interaction of obesity and inflammatory bowel disease. World J Gastroenterol. 2016;22:7868\u201381.","journal-title":"World J Gastroenterol"},{"key":"1037_CR13","doi-asserted-by":"publisher","first-page":"660","DOI":"10.2471\/BLT.07.043497","volume":"85","author":"M de Onis","year":"2007","unstructured":"de Onis M, Onyango AW, Borghi E, et al. Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ. 2007;85:660\u20137.","journal-title":"Bull World Health Organ"},{"key":"1037_CR14","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1053\/j.gastro.2017.01.046","volume":"152","author":"N Abate","year":"2017","unstructured":"Abate N, Chandalia M. Risk of obesity-related cardiometabolic complications in special populations: a crisis in Asians. Gastroenterology. 2017;152:1647\u201355.","journal-title":"Gastroenterology"},{"key":"1037_CR15","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1002\/app5.132","volume":"3","author":"KJ Mumford","year":"2016","unstructured":"Mumford KJ. Prosperity, sustainability and the measurement of wealth. Asia Pac Policy Stud. 2016;3:226\u201334.","journal-title":"Asia Pac Policy Stud"},{"key":"1037_CR16","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1038\/ajg.2009.190","volume":"104","author":"JK Hou","year":"2009","unstructured":"Hou JK, El-Serag H, Thirumurthi S. Distribution and manifestations of inflammatory bowel disease in Asians, Hispanics, and African Americans: a systematic review. Am J Gastroenterol. 2009;104:2100\u20139.","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"1037_CR17","first-page":"237","volume":"25","author":"A Ponder","year":"2013","unstructured":"Ponder A, Long MD. A clinical review of recent findings in the epidemiology of inflammatory bowel disease. Clin Epidemiol. 2013;25(5):237\u201347.","journal-title":"Clin Epidemiol"},{"key":"1037_CR18","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41395-018-0233-2","volume":"114","author":"SC Ng","year":"2019","unstructured":"Ng SC, Kaplan GG, Tang W, et al. Population density and risk of inflammatory bowel disease: a prospective population-based study in 13 countries or regions in Asia\u2013Pacific. Am J Gastroenterol. 2019;114:107\u201315.","journal-title":"Am J Gastroenterol"},{"issue":"11 Suppl 1","key":"1037_CR19","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1210\/jc.2008-1356","volume":"93","author":"ES Ford","year":"2008","unstructured":"Ford ES, Mokdad AH. Epidemiology of obesity in the western hemisphere. J Clin Endocrinol Metab. 2008;93(11 Suppl 1):S1\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"1037_CR20","first-page":"3267","volume":"15","author":"T Trivedi","year":"2015","unstructured":"Trivedi T, Liu J, Probst J, et al. Obesity and obesity-related behaviors among rural and urban adults in the USA. Rural Remote Health. 2015;15:3267.","journal-title":"Rural Remote Health"},{"key":"1037_CR21","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/ijo.2015.140","volume":"40","author":"RM Carrillo-Larco","year":"2016","unstructured":"Carrillo-Larco RM, Bernab\u00e9-Ortiz A, Pillay TD, et al. Obesity risk in rural, urban and rural-to-urban migrants: prospective results of the PERU MIGRANT study. Int J Obes (Lond). 2016;40:181\u20135.","journal-title":"Int J Obes (Lond)"},{"key":"1037_CR22","first-page":"834","volume":"29","author":"PA Lizana","year":"2016","unstructured":"Lizana PA, Paula CV, Araya L, et al. Body fat distribution, and physical activity in school-age children: an urban and rural comparison in Valpara\u00edso, Chile. Biomed Environ Sci. 2016;29:834\u20139.","journal-title":"Biomed Environ Sci."},{"key":"1037_CR23","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.ahj.2012.02.025","volume":"163","author":"TF Eagle","year":"2012","unstructured":"Eagle TF, Sheetz A, Gurm R, et al. Understanding childhood obesity in America: linkages between household income, community resources, and children\u2019s behaviors. Am Heart J. 2012;163:836\u201343.","journal-title":"Am Heart J"},{"key":"1037_CR24","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1001\/jama.2012.108099","volume":"308","author":"L Pan","year":"2012","unstructured":"Pan L, Blanck HM, Sherry B, et al. Trends in the prevalence of extreme obesity among US preschool-aged children living in low-income families, 1998\u20132010. JAMA. 2012;308:2563\u20135.","journal-title":"JAMA"},{"key":"1037_CR25","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1093\/ije\/9.3.227","volume":"9","author":"CF Garland","year":"1980","unstructured":"Garland CF, Garland FC. Do sunlight and vitamin D reduce the likelihood of colon cancer? Int J Epidemiol. 1980;9:227\u201331.","journal-title":"Int J Epidemiol"},{"key":"1037_CR26","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.jsbmb.2006.12.030","volume":"103","author":"WB Grant","year":"2007","unstructured":"Grant WB. A meta-analysis of second cancers after a diagnosis of non-melanoma skin cancer: additional evidence that solar ultraviolet -B irradiance reduces the risk of internal cancers. J Steroid Biochem Mol Biol. 2007;103:668\u201374.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"1037_CR27","doi-asserted-by":"publisher","first-page":"17","DOI":"10.4161\/derm.1.1.7388","volume":"1","author":"WB Grant","year":"2009","unstructured":"Grant WB. How strong is the evidence that solar ultraviolet B and vitamin D reduce the risk of cancer? Dermatoendocrinol. 2009;1:17\u201324.","journal-title":"Dermatoendocrinol"},{"key":"1037_CR28","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1002\/ijc.28081","volume":"133","author":"MT van Leeuwen","year":"2013","unstructured":"van Leeuwen MT, Turner JJ, Falster MO, et al. Latitude gradients for lymphoid neoplasm subtypes in Australia support an association with ultraviolet radiation exposure. Int J Cancer. 2013;133:944\u201351.","journal-title":"Int J Cancer"},{"key":"1037_CR29","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.amepre.2011.04.003","volume":"41","author":"SB Mohr","year":"2011","unstructured":"Mohr SB, Garland CF, Gorham ED, et al. Ultraviolet light B and incidence rates of leukemia worldwide. Am J Prev Med. 2011;41:68\u201374.","journal-title":"Am J Prev Med"},{"key":"1037_CR30","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1136\/jnnp.2011.240432","volume":"82","author":"S Simpson Jr","year":"2011","unstructured":"Simpson S Jr, Blizzard L, Otahal P, et al. Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis. J Neurol Neurosurg Psychiatry. 2011;82:1132\u201341.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1037_CR31","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1053\/j.gastro.2011.11.040","volume":"142","author":"AN Ananathakrishnan","year":"2012","unstructured":"Ananathakrishnan AN, Khalili H, Higuchi LM, et al. Higher predicted vitamin D status is associated with reduced risk of Crohn\u2019s disease. Gastroenterology. 2012;142:482\u20139.","journal-title":"Gastroenterology"},{"key":"1037_CR32","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.mehy.2009.01.022","volume":"73","author":"L Peyrin-Biroulet","year":"2009","unstructured":"Peyrin-Biroulet L, Oussalah A, Bigard M-A. Crohn\u2019s disease: the hot hypothesis. Med Hypotheses. 2009;73:94\u20136.","journal-title":"Med Hypotheses"},{"key":"1037_CR33","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1079\/BJN2003837","volume":"89","author":"A Zitterman","year":"2003","unstructured":"Zitterman A. Vitamin D, in preventive medicine: are we ignoring the evidence? Br J Nutr. 2003;89:552\u201372.","journal-title":"Br J Nutr"},{"key":"1037_CR34","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1177\/153537020422901108","volume":"229","author":"MT Cantorna","year":"2004","unstructured":"Cantorna MT, Mahon BD. Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp Biol Med (Maywood). 2004;229:1136\u201342.","journal-title":"Exp Biol Med (Maywood)"},{"issue":"2","key":"1037_CR35","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1136\/gut.47.2.211","volume":"47","author":"JD Simmons","year":"2000","unstructured":"Simmons JD, Mullighan C, Welsh KI, Jewell DP. Vitamin D receptor gene polymorphism: association with Crohn\u2019s disease susceptibility. Gut. 2000;47(2):211\u20134.","journal-title":"Gut"},{"issue":"12","key":"1037_CR36","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1111\/j.1440-1746.2008.05525.x","volume":"23","author":"N Naderi","year":"2008","unstructured":"Naderi N, Farnood A, Habibi M, Derakhshan F, Balaii H, Motahari Z, Agah MR, Firouzi F, Rad MG, Aghazadeh R, Zojaji H, Zali MR. Association of vitamin D receptor gene polymorphisms in Iranian patients with inflammatory bowel disease. J Gastroenterol Hepatol. 2008;23(12):1816\u201322.","journal-title":"J Gastroenterol Hepatol"},{"issue":"2","key":"1037_CR37","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1093\/ecco-jcc\/jju004","volume":"9","author":"T Hlavaty","year":"2015","unstructured":"Hlavaty T, Krajcovicova A, Payer J. Vitamin D therapy in inflammatory bowel diseases: who, in what form, and how much? J Crohns Colitis. 2015;9(2):198\u2013209.","journal-title":"J Crohns Colitis."},{"issue":"4","key":"1037_CR38","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1074\/jbc.C109.071225","volume":"285","author":"TT Wang","year":"2010","unstructured":"Wang TT, Dabbas B, Laperriere D, Bitton AJ, Soualhine H, Tavera-Mendoza LE, Dionne S, Servant MJ, Bitton A, Seidman EG, Mader S, Behr MA, White JH. Direct and indirect induction by 1,25-dihydroxyvitamin D3 of the NOD2\/CARD15-defensin beta2 innate immune pathway defective in Crohn disease. J Biol Chem. 2010;285(4):2227\u201331.","journal-title":"J Biol Chem"},{"issue":"12","key":"1037_CR39","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/1471-230X-12-57","volume":"30","author":"H Zhao","year":"2012","unstructured":"Zhao H, Zhang H, Wu H, Li H, Liu L, Guo J, Li C, Shih DQ, Zhang X. Protective role of 1,25(OH)2 vitamin D3 in the mucosal injury and epithelial barrier disruption in DSS-induced acute colitis in mice. BMC Gastroenterol. 2012;30(12):57.","journal-title":"BMC Gastroenterol"},{"key":"1037_CR40","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3945\/ajcn.111.014779","volume":"95","author":"A Zitterman","year":"2012","unstructured":"Zitterman A, Iodice S, Pilz S, et al. Vitamin D deficiency and mortality risk in the general population: a meta-analysis of prospective cohort studies. Am J Clin Nutr. 2012;95:91\u2013100.","journal-title":"Am J Clin Nutr"},{"key":"1037_CR41","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/S2213-8587(17)30357-1","volume":"5","author":"P Autier","year":"2017","unstructured":"Autier P, Mullie P, Macacu A, et al. Effect of vitamin D supplementation on non-skeletal disorders: a systematic review of meta-analyses and randomized trials. Lancet Diabetes Endocrinol. 2017;5:986\u20131004.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"1037_CR42","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1177\/0148607113504002","volume":"38","author":"ZA Zator","year":"2014","unstructured":"Zator ZA, Cantu SM, Konijeti GG, Nguyen DD, Sauk J, Yajnik V, Ananthakrishnan AN. Pretreatment 25-hydroxyvitamin D levels and durability of anti-tumor necrosis factor-\u03b1 therapy in inflammatory bowel diseases. JPEN J Parenter Enteral Nutr. 2014;38(3):385\u201391.","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"1037_CR43","doi-asserted-by":"publisher","first-page":"e12662","DOI":"10.1097\/MD.0000000000012662","volume":"97","author":"J Li","year":"2018","unstructured":"Li J, Chen N, Wang D, et al. Efficacy of vitamin D in treatment of inflammatory bowel disease: a meta-analysis. Medicine (Baltimore). 2018;97:e12662.","journal-title":"Medicine (Baltimore)"},{"key":"1037_CR44","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/S2468-1253(17)30154-1","volume":"2","author":"CL Storhaug","year":"2017","unstructured":"Storhaug CL, Fosse SK, Fadnes LT. Country, regional, and global estimates for lactose malabsorption in adults: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2017;2:738\u201346.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"1037_CR45","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1471-2148-10-36","volume":"10","author":"Y Itan","year":"2010","unstructured":"Itan Y, Jones BL, Ingram CJ, et al. A worldwide correlation of lactase persistence phenotype and genotypes. BMC Evol Biol. 2010;10:36.","journal-title":"BMC Evol Biol"},{"key":"1037_CR46","first-page":"44","volume":"2","author":"A Szilagyi","year":"2018","unstructured":"Szilagyi A. Complex interactions of obesity, dairy food intake and genetics of lactase. J Obs Chronic Dis. 2018;2:44\u201354.","journal-title":"J Obs Chronic Dis"},{"key":"1037_CR47","unstructured":"Obesity Update site (OECD). 2012. \nhttp:\/\/www.oecd.org\/els\/health-systems\/Obesity-Update-2014.pdf\n\n. Accessed 23 June 2019."},{"key":"1037_CR48","unstructured":"Obesity Update site (OECD). 2015. \nhttps:\/\/www.oecd.org\/els\/health-systems\/Obesity-Update-2017.pdf\n\n. Accessed 23 June 23 2019."},{"key":"1037_CR49","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1080\/01635581.2011.596641","volume":"63","author":"A Szilagyi","year":"2011","unstructured":"Szilagyi A, Leighton H, Burstein B, et al. Significant positive correlation between sunshine and lactase nonpersistence in Europe may implicate both in similarly altering risks for some diseases. Nutr Cancer. 2011;63:991\u20139.","journal-title":"Nutr Cancer"},{"key":"1037_CR50","doi-asserted-by":"publisher","first-page":"128","DOI":"10.17925\/EE.2013.09.02.128","volume":"9","author":"FR de Azevedo","year":"2013","unstructured":"de Azevedo FR, Caramelli B. Hypovitaminosis D and obesity\u2014coincidence or consequence? Eur Endocrinol. 2013;9:128\u201331.","journal-title":"Eur Endocrinol"},{"key":"1037_CR51","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1093\/nutrit\/nux056","volume":"76","author":"CF Dix","year":"2018","unstructured":"Dix CF, Barcley JL, Wright ORL. The role of vitamin D in adipogenesis. Nutr Rev. 2018;76:47\u201359.","journal-title":"Nutr Rev"},{"key":"1037_CR52","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/obr.12162","volume":"15","author":"K Pathak","year":"2014","unstructured":"Pathak K, Soares MJ, Calton EK, et al. Vitamin D supplementation and body weight status: a systematic review and meta-analysis of randomized controlled trials. Obes Rev. 2014;15:528\u201337.","journal-title":"Obes Rev"},{"key":"1037_CR53","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.mayocp.2018.09.013","volume":"94","author":"GP Ramos","year":"2019","unstructured":"Ramos GP, Papadakis KA. Mechanisms of disease: inflammatory bowel diseases. Mayo Clin Proc. 2019;94:155\u201365.","journal-title":"Mayo Clin Proc"},{"key":"1037_CR54","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.gtc.2016.04.010","volume":"45","author":"LE Wroblewski","year":"2016","unstructured":"Wroblewski LE, Peek RM Jr, Coburn LA. The role of the microbiome in gastrointestinal cancer. Gastroenterol Clin North Am. 2016;45:543\u201356.","journal-title":"Gastroenterol Clin North Am"},{"key":"1037_CR55","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/hep4.1284","volume":"3","author":"SR Sharpton","year":"2018","unstructured":"Sharpton SR, Yong GJM, Terrault NA, et al. Gut microbial metabolism and nonalcoholic fatty liver disease. Hepatol Commun. 2018;3:29\u201343.","journal-title":"Hepatol Commun"},{"key":"1037_CR56","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3389\/fmed.2018.00349","volume":"5","author":"CS Guerreiro","year":"2018","unstructured":"Guerreiro CS, Calado \u00c2, Sousa J, et al. Diet, microbiota, and gut permeability\u2014the unknown triad in rheumatoid arthritis. Front Med (Lausanne). 2018;5:349.","journal-title":"Front Med (Lausanne)"},{"key":"1037_CR57","doi-asserted-by":"publisher","first-page":"4750","DOI":"10.3748\/wjg.v24.i42.4750","volume":"24","author":"Y Shimizu","year":"2018","unstructured":"Shimizu Y. Gut microbiota in common elderly diseases affecting activities of daily living. World J Gastroenterol. 2018;24:4750\u20138.","journal-title":"World J Gastroenterol"},{"issue":"13","key":"1037_CR58","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1186\/1471-2458-13-530","volume":"31","author":"G Aamodt","year":"2013","unstructured":"Aamodt G, Bengtson MB, Vatn MH. Can temperature explain the latitudinal gradient of ulcerative colitis? Cohort of Norway. BMC Public Health. 2013;31(13):530.","journal-title":"BMC Public Health"},{"key":"1037_CR59","first-page":"39","volume":"5","author":"E Dikongu\u00e9","year":"2017","unstructured":"Dikongu\u00e9 E, S\u00e9gurel L. Latitude as a co-driver of human gut microbial diversity? Bioessays. 2017;5:39.","journal-title":"Bioessays"},{"issue":"962\u2013972","key":"1037_CR60","first-page":"e10","volume":"175","author":"P Vangay","year":"2018","unstructured":"Vangay P, Johnson AJ, Ward TL, et al. US Immigration westernizes the human gut microbiome. Cell. 2018;175(962\u2013972):e10.","journal-title":"Cell"},{"key":"1037_CR61","first-page":"1","volume-title":"Lactose evolutionary role, health effects, and applications","author":"C Walker","year":"2019","unstructured":"Walker C, Thomas MG. The evolution of lactose digestion. In: Paques M, Lindner C, editors. Lactose evolutionary role, health effects, and applications. London: Academic Press; 2019. p. 1\u201335."},{"key":"1037_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0306-9877(86)90131-3","volume":"19","author":"AA Nanji","year":"1986","unstructured":"Nanji AA, Denardi FG. Primary adult lactose intolerance protects against development of inflammatory bowel disease. Med Hypotheses. 1986;19:1\u20136.","journal-title":"Med Hypotheses"},{"key":"1037_CR63","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1080\/01635580701745301","volume":"60","author":"I Shrier","year":"2008","unstructured":"Shrier I, Szilagyi A, Correa JA. Impact of lactose containing foods and the genetics of lactase on diseases: an analytical review of population data. Nutr Cancer. 2008;60:292\u2013300.","journal-title":"Nutr Cancer"},{"key":"1037_CR64","doi-asserted-by":"publisher","first-page":"183","DOI":"10.2147\/CLEP.S59838","volume":"6","author":"A Szilagyi","year":"2014","unstructured":"Szilagyi A, Leighton H, Burstein B, et al. Latitude, sunshine, and human lactase phenotype distributions may contribute to geographic patterns of modern disease: the inflammatory bowel disease model. Clin Epidemiol. 2014;6:183\u201398.","journal-title":"Clin Epidemiol"},{"key":"1037_CR65","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.mehy.2016.10.001","volume":"96","author":"A Szilagyi","year":"2016","unstructured":"Szilagyi A, Xue X. Geographic associations between lactase phenotype, multiple sclerosis, and inflammatory bowel diseases; does obesity trump geography? Med Hypotheses. 2016;96:68\u201372.","journal-title":"Med Hypotheses"},{"key":"1037_CR66","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s00251-008-0274-6","volume":"60","author":"C Gasche","year":"2008","unstructured":"Gasche C, Nemeth M, Grundtner P, et al. Evolution of Crohn\u2019s disease-associated Nod2 mutations. Immunogenetics. 2008;60:115\u201320.","journal-title":"Immunogenetics"},{"key":"1037_CR67","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/sj.ejhg.5201749","volume":"15","author":"G Modiano","year":"2007","unstructured":"Modiano G, Ciminellui BM, Pignatti PF. Cystic fibrosis and lactase persistence: a possible correlation. Eur J Hum Genet. 2007;15:255\u20139.","journal-title":"Eur J Hum Genet"},{"key":"1037_CR68","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.mehy.2009.12.018","volume":"74","author":"MA Alfonso-Sanchez","year":"2010","unstructured":"Alfonso-Sanchez MA, Perez-Miranda AM, Garcia-Obregon S, et al. An evolutionary approach to the high frequency of the delta F508 CFTR mutation in European populations. Med Hypotheses. 2010;74:989\u201392.","journal-title":"Med Hypotheses"},{"key":"1037_CR69","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1002\/ajpa.1330800302","volume":"80","author":"RR Sokal","year":"1989","unstructured":"Sokal RR, Harding RM, Oden NL. Spatial patterns of human gene frequencies in Europe. Am J Phys Anthropol. 1989;80:267\u201394.","journal-title":"Am J Phys Anthropol"},{"key":"1037_CR70","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/S0140-6736(04)15824-8","volume":"363","author":"J Bradbury","year":"2004","unstructured":"Bradbury J. Ancient footsteps in our genes: evolution and human disease. Gene variants selected during evolution may underlie many common diseases. Lancet. 2004;363:952\u20133.","journal-title":"Lancet"},{"key":"1037_CR71","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1136\/gut.33.5.687","volume":"33","author":"CS Probert","year":"1992","unstructured":"Probert CS, Jayanthi V, Pinder D, et al. Epidemiological study of ulcerative proctocolitis in Indian migrants and the indigenous population of Leicestershire. Gut. 1992;33:687\u201393.","journal-title":"Gut"},{"key":"1037_CR72","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/ajg.2015.52","volume":"110","author":"EI Benchimol","year":"2015","unstructured":"Benchimol EI, Mack DR, Guttmann A, et al. Inflammatory bowel disease in immigrants to Canada and their children: a population-based cohort study. Am J Gastroenterol. 2015;110:553\u201363.","journal-title":"Am J Gastroenterol"},{"key":"1037_CR73","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12937-016-0183-8","volume":"15","author":"A Szilagyi","year":"2016","unstructured":"Szilagyi A, Galiatsatos P, Xue X. Systematic review and meta-analysis of lactose digestion, its impact on intolerance and nutritional effects of dairy food restriction in inflammatory bowel diseases. Nutr J. 2016;15:67.","journal-title":"Nutr J"},{"key":"1037_CR74","unstructured":"GINI Index. World bank estimate: listing the values by country. \nhttps:\/\/www.indexmundi.com\/facts\/indicators\/SI.POV.GINI\/rankings\n\n. Accessed 29 April 2019."},{"issue":"5249","key":"1037_CR75","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1126\/science.271.5249.665","volume":"271","author":"GS Hotamisligil","year":"1996","unstructured":"Hotamisligil GS, Peraldi P, Budavari A, et al. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science. 1996;271(5249):665\u20138.","journal-title":"Science"},{"key":"1037_CR76","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1093\/jmcb\/mjw011","volume":"8","author":"ZV Wang","year":"2016","unstructured":"Wang ZV, Scherer PE. Adiponectin, the past two decades. J Mol Cell Biol. 2016;8:93\u2013100.","journal-title":"J Mol Cell Biol"},{"key":"1037_CR77","doi-asserted-by":"publisher","first-page":"4727","DOI":"10.1172\/JCI91578","volume":"126","author":"J Friedman","year":"2016","unstructured":"Friedman J. The long road to leptin. J Clin Invest. 2016;126:4727\u201334.","journal-title":"J Clin Invest"},{"key":"1037_CR78","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.cytogfr.2017.03.001","volume":"35","author":"A P\u00e9rez-P\u00e9rez","year":"2017","unstructured":"P\u00e9rez-P\u00e9rez A, Vilari\u00f1o-Garc\u00eda T, Fern\u00e1ndez-Riejos P, et al. Role of leptin as a link between metabolism and the immune system. Cytokine Growth Factor Rev. 2017;35:71\u201384.","journal-title":"Cytokine Growth Factor Rev"},{"key":"1037_CR79","doi-asserted-by":"publisher","first-page":"883","DOI":"10.2174\/1567205014666170216152905","volume":"14","author":"DW Nixon","year":"2017","unstructured":"Nixon DW. The inverse relationship between cancer and Alzheimer\u2019s disease: a possible mechanism. Curr Alzheimer Res. 2017;14:883\u201393.","journal-title":"Curr Alzheimer Res"},{"key":"1037_CR80","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1111\/j.1476-5381.2011.01369.x","volume":"165","author":"MS Jamaluddin","year":"2012","unstructured":"Jamaluddin MS, Weakley SM, Yao Q, et al. Resistin: functional roles and therapeutic considerations for cardiovascular disease. Br J Pharmacol. 2012;165:622\u201332.","journal-title":"Br J Pharmacol"},{"key":"1037_CR81","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1002\/cphy.c160043","volume":"7","author":"T Watanabe","year":"2017","unstructured":"Watanabe T, Watanabe-Kominato K, Takahashi Y, et al. Adipose tissue-derived omentin-1 function and regulation. Compr Physiol. 2017;7:765\u201381.","journal-title":"Compr Physiol"},{"key":"1037_CR82","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.diabres.2011.10.004","volume":"95","author":"S Akbarzadeh","year":"2012","unstructured":"Akbarzadeh S, Nabipour I, Jafari SM, et al. Serum visfatin and vaspin levels in normoglycemic first-degree relatives of Iranian patients with type 2 diabetes mellitus. Diabetes Res Clin Pract. 2012;95:132\u20138.","journal-title":"Diabetes Res Clin Pract"},{"issue":"6382","key":"1037_CR83","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1126\/science.aar3318","volume":"359","author":"CA Thaiss","year":"2018","unstructured":"Thaiss CA, Levy M, Grosheva I, et al. Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection. Science. 2018;359(6382):1376\u201383.","journal-title":"Science"},{"key":"1037_CR84","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.2337\/dc10-0556","volume":"33","author":"G Musso","year":"2010","unstructured":"Musso G, Gambino R, Cassader M. Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded? Diabetes Care. 2010;33:2277\u201384.","journal-title":"Diabetes Care"},{"issue":"39","key":"1037_CR85","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1210\/er.2017-00192","volume":"2018","author":"AS Meijnikman","year":"2018","unstructured":"Meijnikman AS, Gerdes VE, Nieuwdorp M, et al. Evaluating causality of gut microbiota in obesity and diabetes in humans. Endocr Rev. 2018;2018(39):133\u201353.","journal-title":"Endocr Rev"},{"key":"1037_CR86","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12328-017-0813-5","volume":"11","author":"A Nishida","year":"2018","unstructured":"Nishida A, Inoue R, Inatomi O, et al. Gut microbiota in the pathogenesis of inflammatory bowel disease. Clin J Gastroenterol. 2018;11:1\u201310.","journal-title":"Clin J Gastroenterol"},{"key":"1037_CR87","first-page":"318131","volume":"2018","author":"T Zuo","year":"2019","unstructured":"Zuo T, Lu XJ, Zhang Y, et al. Gut mucosal virome alterations in ulcerative colitis. Gut. 2019;2018:318131.","journal-title":"Gut"},{"key":"1037_CR88","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1097\/MIB.0000000000000454","volume":"21","author":"C Chehoud","year":"2015","unstructured":"Chehoud C, Albenberg LG, Judge C, et al. Fungal signature in the gut microbiota of pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis. 2015;21:1948\u201356.","journal-title":"Inflamm Bowel Dis"},{"key":"1037_CR89","doi-asserted-by":"publisher","first-page":"e87734","DOI":"10.1371\/journal.pone.0087734","volume":"9","author":"PB Lecours","year":"2014","unstructured":"Lecours PB, Marsolais D, Cormier Y, et al. Increased prevalence of Methanosphaera stadtmanae in inflammatory bowel diseases. PLoS One. 2014;9:e87734.","journal-title":"PLoS One"},{"key":"1037_CR90","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1111\/cmi.12308","volume":"16","author":"C Petersen","year":"2014","unstructured":"Petersen C, Round JL. Defining dysbiosis and its influence on host immunity and disease. Cell Microbiol. 2014;16:1024\u201333.","journal-title":"Cell Microbiol"},{"issue":"22","key":"1037_CR91","doi-asserted-by":"publisher","first-page":"4223","DOI":"10.1016\/j.febslet.2014.09.039","volume":"588","author":"WA Walters","year":"2014","unstructured":"Walters WA, Xu Z, Knight R. Meta-analyses of human gut microbes associated with obesity and IBD. FEBS Lett. 2014;588(22):4223\u201333.","journal-title":"FEBS Lett"},{"key":"1037_CR92","doi-asserted-by":"publisher","first-page":"16643","DOI":"10.1038\/srep16643","volume":"5","author":"M Schneeberger","year":"2015","unstructured":"Schneeberger M, Everard A, G\u00f3mez-Valad\u00e9s AG, et al. Akkermansia muciniphila inversely correlates with the onset of inflammation, altered adipose tissue metabolism and metabolic disorders during obesity in mice. Sci Rep. 2015;5:16643.","journal-title":"Sci Rep."},{"key":"1037_CR93","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3389\/fcimb.2018.00281","volume":"8","author":"M Lopez-Siles","year":"2018","unstructured":"Lopez-Siles M, Enrich-Cap\u00f3 N, Aldeguer X, et al. Alterations in the abundance and co-occurrence of Akkermansia muciniphila and Faecalibacterium prausnitzii in the colonic mucosa of inflammatory bowel disease subjects. Front Cell Infect Microbiol. 2018;8:281.","journal-title":"Front Cell Infect Microbiol."},{"key":"1037_CR94","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1093\/ecco-jcc\/jjv147","volume":"9","author":"J Maukonen","year":"2015","unstructured":"Maukonen J, Kolho KL, Paasela M, et al. Altered Fecal microbiota in paediatric inflammatory bowel disease. J Crohn\u2019s Colitis. 2015;9:1088\u201395.","journal-title":"J Crohn\u2019s Colitis."},{"issue":"12","key":"1037_CR95","doi-asserted-by":"publisher","first-page":"E607","DOI":"10.1002\/oby.20466","volume":"21","author":"FJ Verdam","year":"2013","unstructured":"Verdam FJ, Fuentes S, de Jonge C, et al. Human intestinal microbiota composition is associated with local and systemic inflammation in obesity. Obesity (Silver Spring). 2013;21(12):E607\u201315.","journal-title":"Obesity (Silver Spring)."},{"key":"1037_CR96","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1136\/gutjnl-2013-304833","volume":"63","author":"K Machiels","year":"2014","unstructured":"Machiels K, Joossens M, Sabino J, et al. A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut. 2014;63:1275\u201383.","journal-title":"Gut"},{"key":"1037_CR97","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1159\/000441768","volume":"93","author":"K Takahashi","year":"2016","unstructured":"Takahashi K, Nishida A, Fujimoto T, et al. Reduced abundance of butyrate-producing bacteria species in the fecal microbial community in Crohn\u2019s disease. Digestion. 2016;93:59\u201365.","journal-title":"Digestion."},{"key":"1037_CR98","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s12876-016-0540-2","volume":"16","author":"M Pilarczyk-Zurek","year":"2016","unstructured":"Pilarczyk-Zurek M, Strus M, Adamski P, et al. The dual role of Escherichia coli in the course of ulcerative colitis. BMC Gastroenterol. 2016;16:128.","journal-title":"BMC Gastroenterol."},{"key":"1037_CR99","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1038\/oby.2012.110","volume":"20","author":"CL Karlsson","year":"2012","unstructured":"Karlsson CL, Onnerf\u00e4lt J, Xu J, et al. The microbiota of the gut in preschool children with normal and excessive body weight. Obesity (Silver Spring). 2012;20:2257\u201361.","journal-title":"Obesity (Silver Spring)."},{"key":"1037_CR100","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1002\/ibd.21590","volume":"17","author":"SC Ng","year":"2011","unstructured":"Ng SC, Benjamin JL, McCarthy NE, et al. Relationship between human intestinal dendritic cells, Gut microbiota, and disease activity in Crohn\u2019s disease. Inflamm Bowel Dis. 2011;17:2027\u201337.","journal-title":"Inflamm Bowel Dis"},{"key":"1037_CR101","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2217\/fmb-2016-0130","volume":"12","author":"Z Tamanai-Shacoori","year":"2017","unstructured":"Tamanai-Shacoori Z, Smida I, Bousarghin L, et al. Roseburia spp.: a marker of health? Future Microbiol. 2017;12:157\u201370.","journal-title":"Future Microbiol."},{"key":"1037_CR102","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12887-015-0384-x","volume":"15","author":"X Gao","year":"2015","unstructured":"Gao X, Jia R, Xie L, et al. Obesity in school-aged children and its correlation with gut E. coli and Bifidobacteria: a case-control study. BMC Pediatr. 2015;15:64.","journal-title":"BMC Pediatr."},{"key":"1037_CR103","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13073-017-0490-5","volume":"9","author":"AB Hall","year":"2017","unstructured":"Hall AB, Yassour M, Sauk J, et al. A novel Ruminococcus gnavus clade enriched in inflammatory bowel disease patients. Genome Med. 2017;9:103.","journal-title":"Genome Med."},{"key":"1037_CR104","doi-asserted-by":"publisher","first-page":"e0170034","DOI":"10.1371\/journal.pone.0170034","volume":"12","author":"S Vrakas","year":"2017","unstructured":"Vrakas S, Mountzouris KC, Michalopoulos G, et al. Intestinal bacteria composition and translocation of bacteria in inflammatory bowel disease. PLoS One. 2017;12:e0170034.","journal-title":"PLoS One"},{"key":"1037_CR105","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.3945\/ajcn.2010.29877","volume":"92","author":"MC Collado","year":"2010","unstructured":"Collado MC, Isolauri E, Laitinen K, et al. Effect of mother\u2019s weight on infant\u2019s microbiota acquisition, composition, and activity during early infancy: a prospective follow-up study initiated in early pregnancy. Am J Clin Nutr. 2010;92:1023\u201330.","journal-title":"Am J Clin Nutr"},{"key":"1037_CR106","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/B978-0-12-407825-3.00011-3","volume-title":"Diet-Microbe Interactions in the Gut","author":"Q Shen","year":"2015","unstructured":"Shen Q, Maitin V. Obesity-associated gut microbiota: characterization and dietary modulation. In: Tuohy K, Del Rio D, editors. Diet-Microbe Interactions in the Gut. London: Academic Press, Elsevier; 2015. p. 149\u201371."},{"key":"1037_CR107","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jnutbio.2010.10.008","volume":"23","author":"AM Neyrinck","year":"2012","unstructured":"Neyrinck AM, Possemiers S, Verstraete W, et al. Dietary modulation of clostridial cluster XIVa gut bacteria (Roseburia spp.) by chitin-glucan fiber improves host metabolic alterations induced by high-fat diet in mice. J Nutr Biochem. 2012;23:51\u20139.","journal-title":"J Nutr Biochem."},{"key":"1037_CR108","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1136\/gut.2010.223263","volume":"60","author":"M Joossens","year":"2011","unstructured":"Joossens M, Huys G, Cnockaert M, et al. Dysbiosis of the faecal microbiota in patients with Crohn\u2019s disease and their unaffected relatives. Gut. 2011;60:631\u20137.","journal-title":"Gut"},{"key":"1037_CR109","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.jcmgh.2016.02.003","volume":"2","author":"H Nagao-Kitamoto","year":"2016","unstructured":"Nagao-Kitamoto H, Shreiner AB, Gillilland MG 3rd, et al. Functional characterization of inflammatory bowel disease-associated gut dysbiosis in gnotobiotic mice. Cell Mol Gastroenterol Hepatol. 2016;2:468\u201381 (eCollection 2016 Jul.).","journal-title":"Cell Mol Gastroenterol Hepatol."},{"key":"1037_CR110","doi-asserted-by":"publisher","first-page":"e0187515","DOI":"10.1371\/journal.pone.0187515","volume":"12","author":"JC Lee","year":"2017","unstructured":"Lee JC, Lee HY, Kim TK, et al. Obesogenic diet-induced gut barrier dysfunction and pathobiont expansion aggravate experimental colitis. PLoS One. 2017;12:e0187515.","journal-title":"PLoS One."},{"key":"1037_CR111","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.cld.2015.10.001","volume":"20","author":"M Sayiner","year":"2016","unstructured":"Sayiner M, Koenig A, Henry L, et al. Epidemiology of nonalcoholic fatty liver disease and nonalcoholic Steatohepatitis in the United States and the rest of the world. Clin Liver Dis. 2016;20:205\u201314.","journal-title":"Clin Liver Dis"},{"key":"1037_CR112","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/obr.12407","volume":"17","author":"L Li","year":"2016","unstructured":"Li L, Liu DW, Yan HY, et al. Obesity is an independent risk factor for non-alcoholic fatty liver disease: evidence from a meta-analysis of 21 cohort studies. Obes Rev. 2016;17:510\u20139.","journal-title":"Obes Rev"},{"key":"1037_CR113","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/apt.12794","volume":"40","author":"E Gizard","year":"2014","unstructured":"Gizard E, Ford AC, Bronowicki JP, et al. Systematic review: the epidemiology of the hepatobiliary manifestations in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2014;40:3\u201315.","journal-title":"Aliment Pharmacol Ther"},{"key":"1037_CR114","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1097\/MIB.0000000000000832","volume":"22","author":"T Bessissow","year":"2016","unstructured":"Bessissow T, Le NH, Rollet K, et al. Incidence and predictors of nonalcoholic fatty liver disease by serum biomarkers in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2016;22:1937\u201344.","journal-title":"Inflamm Bowel Dis"},{"key":"1037_CR115","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1093\/ibd\/izy200","volume":"25","author":"C Saroli Palumbo","year":"2019","unstructured":"Saroli Palumbo C, Restellini S, Chao CY, et al. Screening for nonalcoholic fatty liver disease in inflammatory bowel diseases: a cohort study using transient elastography. Inflamm Bowel Dis. 2019;25:124\u201333.","journal-title":"Inflamm Bowel Dis"},{"key":"1037_CR116","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1007\/s10620-017-4495-0","volume":"62","author":"RM Carr","year":"2017","unstructured":"Carr RM, Patel A, Bownik H, et al. Intestinal inflammation does not predict nonalcoholic fatty liver disease severity in inflammatory bowel disease patients. Dig Dis Sci. 2017;62:1354\u201361.","journal-title":"Dig Dis Sci"},{"key":"1037_CR117","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1093\/ibd\/izy051","volume":"24","author":"M Principi","year":"2018","unstructured":"Principi M, Iannone A, Losurdo G, et al. Nonalcoholic fatty liver disease in inflammatory bowel disease: prevalence and risk factors. Inflamm Bowel Dis. 2018;24:1589\u201396.","journal-title":"Inflamm Bowel Dis"},{"key":"1037_CR118","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.cgh.2016.08.028","volume":"15","author":"D Kim","year":"2017","unstructured":"Kim D, Kim WR. Nonobese fatty liver disease. Clin Gastroenterol Hepatol. 2017;15:474\u201385.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1037_CR119","doi-asserted-by":"publisher","first-page":"e0206450","DOI":"10.1371\/journal.pone.0206450","volume":"13","author":"LC Adams","year":"2018","unstructured":"Adams LC, L\u00fcbbe F, Bressem K, et al. Non-alcoholic fatty liver disease in underweight patients with inflammatory bowel disease: a case-control study. PLoS One. 2018;13:e0206450.","journal-title":"PLoS One"},{"key":"1037_CR120","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.cgh.2018.08.065","volume":"17","author":"SR Sharpton","year":"2019","unstructured":"Sharpton SR, Ajmera V, Loomba R. Emerging role of the gut microbiome in nonalcoholic fatty liver disease: from composition to function. Clin Gastroenterol Hepatol. 2019;17:296\u2013306.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1037_CR121","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.crohns.2013.09.021","volume":"8","author":"M Fumery","year":"2014","unstructured":"Fumery M, Xiaocang C, Dauchet L, et al. Thromboembolic events and cardiovascular mortality in inflammatory bowel diseases: a meta-analysis of observational studies. J Crohns Colitis. 2014;8:469\u201379.","journal-title":"J Crohns Colitis"},{"key":"1037_CR122","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1097\/CRD.0000000000000214","volume":"26","author":"MG Nevulis","year":"2018","unstructured":"Nevulis MG, Baker C, Lebovics E, et al. Overview of link between inflammatory bowel disease and cardiovascular disease. Cardiol Rev. 2018;26:287\u201393.","journal-title":"Cardiol Rev"},{"key":"1037_CR123","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1097\/MIB.0000000000000899","volume":"22","author":"EL Barnes","year":"2016","unstructured":"Barnes EL, Beery RM, Schulman AR, et al. Hospitalizations for acute myocardial infarction are decreased among patients with inflammatory bowel disease using a nationwide inpatient database. Inflamm Bowel Dis. 2016;22:2229\u201337.","journal-title":"Inflamm Bowel Dis"},{"key":"1037_CR124","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.crohns.2011.01.011","volume":"5","author":"AR Sridhar","year":"2011","unstructured":"Sridhar AR, Parasa S, Navaneethan U, et al. Comprehensive study of cardiovascular morbidity in hospitalized inflammatory bowel disease patients. J Crohns Colitis. 2011;5:287\u201394.","journal-title":"J Crohns Colitis"},{"key":"1037_CR125","first-page":"5892","volume":"6","author":"W Feng","year":"2017","unstructured":"Feng W, Chen G, Cai D, et al. Inflammatory bowel disease and risk of ischemic heart disease: an updated meta-analysis of cohort studies. J Am Heart Assoc. 2017;6:5892.","journal-title":"J Am Heart Assoc"},{"issue":"1607\u20131615","key":"1037_CR126","first-page":"e1","volume":"16","author":"S Aniwan","year":"2018","unstructured":"Aniwan S, Pardi DS, Tremaine WJ, et al. Increased risk of acute myocardial infarction and heart failure in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2018;16(1607\u20131615):e1.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1037_CR127","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.114.009990","volume":"130","author":"A Dregan","year":"2014","unstructured":"Dregan A, Charlton J, Chowienczyk P, et al. Chronic inflammatory disorders and risk of type 2 diabetes mellitus, coronary heart disease, and stroke: a population-based cohort study. Circulation. 2014;130:837\u201344.","journal-title":"Circulation"},{"key":"1037_CR128","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.pharep.2016.04.016","volume":"68","author":"A Michalak","year":"2016","unstructured":"Michalak A, Mosi\u0144ska P, Fichna J. Common links between metabolic syndrome and inflammatory bowel disease: current overview and future perspectives. Pharmacol Rep. 2016;68:837\u201346.","journal-title":"Pharmacol Rep"},{"key":"1037_CR129","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s10620-010-1541-6","volume":"56","author":"MA Mendall","year":"2011","unstructured":"Mendall MA, Gunasekera AV, John BJ, et al. Is obesity a risk factor for Crohn\u2019s disease? Dig Dis Sci. 2011;56:837\u201344.","journal-title":"Dig Dis Sci"},{"key":"1037_CR130","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/ajg.2012.453","volume":"108","author":"SS Chan","year":"2013","unstructured":"Chan SS, Luben R, Olsen A, et al. Body mass index and the risk for Crohn\u2019s disease and ulcerative colitis: data from a European Prospective Cohort Study (The IBD in EPIC Study). Am J Gastroenterol. 2013;108:575\u201382.","journal-title":"Am J Gastroenterol"},{"key":"1037_CR131","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1159\/000262276","volume":"2","author":"H Steed","year":"2009","unstructured":"Steed H, Walsh S, Reynolds N. A brief report of the epidemiology of obesity in the inflammatory bowel disease population of Tayside, Scotland. Obes Facts. 2009;2:370\u20132.","journal-title":"Obes Facts"},{"key":"1037_CR132","doi-asserted-by":"publisher","first-page":"7727","DOI":"10.3748\/wjg.v22.i34.7727","volume":"22","author":"CY Chao","year":"2016","unstructured":"Chao CY, Battat R, Al Khoury A, et al. Co-existence of non-alcoholic fatty liver disease and inflammatory bowel disease: a review article. World J Gastroenterol. 2016;22:7727\u201334.","journal-title":"World J Gastroenterol"},{"key":"1037_CR133","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1097\/MIB.0b013e31829cf401","volume":"19","author":"JW Harper","year":"2013","unstructured":"Harper JW, Sinanan MN, Zisman TL. Increased body mass index is associated with earlier time to loss of response to infliximab in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2013;19:2118\u201324.","journal-title":"Inflamm Bowel Dis"},{"key":"1037_CR134","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/j.1365-2036.2011.04946.x","volume":"35","author":"E Bultman","year":"2012","unstructured":"Bultman E, de Haar C, van Liere-Baron A, et al. Predictors of dose escalation of adalimumab in a prospective cohort of Crohn\u2019s disease patients. Aliment Pharmacol Ther. 2012;35:335\u201341.","journal-title":"Aliment Pharmacol Ther"},{"key":"1037_CR135","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1097\/MEG.0b013e32835d1f15","volume":"25","author":"M Bhalme","year":"2013","unstructured":"Bhalme M, Sharma A, Keld R, et al. Does weight-adjusted anti-tumour necrosis factor treatment favour obese patients with Crohn\u2019s disease? Eur J Gastroenterol Hepatol. 2013;25:543\u20139.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1037_CR136","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1097\/MEG.0000000000000544","volume":"28","author":"A Bond","year":"2016","unstructured":"Bond A, Asher R, Jackson R, et al. Comparative analysis of the influence of clinical factors including BMI on adalimumab and infliximab trough levels. Eur J Gastroenterol Hepatol. 2016;28:271\u20136.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1037_CR137","doi-asserted-by":"publisher","first-page":"e0195123","DOI":"10.1371\/journal.pone.0195123","volume":"13","author":"S Singh","year":"2018","unstructured":"Singh S, Facciorusso A, Singh AG, et al. Obesity and response to anti-tumor necrosis factor-\u03b1 agents in patients with select immune-mediated inflammatory diseases: a systematic review and meta-analysis. PLoS One. 2018;13:e0195123.","journal-title":"PLoS One"},{"issue":"1937\u20131946","key":"1037_CR138","first-page":"e8","volume":"16","author":"E Dreesen","year":"2018","unstructured":"Dreesen E, Verstockt B, Bian S, et al. Evidence to support monitoring of vedolizumab trough concentrations in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2018;16(1937\u20131946):e8.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1037_CR139","doi-asserted-by":"publisher","first-page":"7868","DOI":"10.3748\/wjg.v22.i35.7868","volume":"22","author":"JW Harper","year":"2016","unstructured":"Harper JW, Zisman TL. Interaction of obesity and inflammatory bowel disease. World J Gastroenterol. 2016;22:7868\u201381.","journal-title":"World J Gastroenterol"},{"key":"1037_CR140","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1097\/MIB.0000000000000560","volume":"21","author":"JL Seminerio","year":"2015","unstructured":"Seminerio JL, Koutroubakis IE, Ramos-Rivers C, et al. Impact of obesity on the management and clinical course of patients with inflammatory bowel disease. Inflamm Bowel Dis. 2015;21:2857\u201363.","journal-title":"Inflamm Bowel Dis"},{"key":"1037_CR141","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1159\/000380763","volume":"91","author":"PS Fitzmorris","year":"2015","unstructured":"Fitzmorris PS, Colantonio LD, Torrazza Perez E, et al. Impact of metabolic syndrome on the hospitalization rate of Crohn\u2019s disease patients seen at a tertiary care center: a retrospective cohort study. Digestion. 2015;91:257\u201362.","journal-title":"Digestion"},{"key":"1037_CR142","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1054\/clnu.2001.0503","volume":"21","author":"A Blain","year":"2002","unstructured":"Blain A, Cattan S, Beaugerie L, et al. Crohn\u2019s disease clinical course and severity in obese patients. Clin Nutr. 2002;21:51\u20137.","journal-title":"Clin Nutr"},{"key":"1037_CR143","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1007\/s10620-015-3629-5","volume":"60","author":"A Flores","year":"2015","unstructured":"Flores A, Burstein E, Cipher DJ, et al. Obesity in inflammatory bowel disease: a marker of less severe disease. Dig Dis Sci. 2015;60:2436\u201345.","journal-title":"Dig Dis Sci"},{"key":"1037_CR144","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.12659\/MSM.901969","volume":"23","author":"Q Hu","year":"2017","unstructured":"Hu Q, Ren J, Li G, et al. The impact of obesity on the clinical course of inflammatory bowel disease: a meta-analysis. Med Sci Monit. 2017;23:2599\u2013606.","journal-title":"Med Sci Monit"},{"issue":"2","key":"1037_CR145","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1097\/MIB.0000000000000283","volume":"21","author":"H Khalili","year":"2015","unstructured":"Khalili H, Ananthakrishnan AN, Konijeti GG, Higuchi LM, Fuchs CS, Richter JM, Chan AT. Inflamm measures of obesity and risk of Crohn\u2019s disease and ulcerative colitis. Bowel Dis. 2015;21(2):361\u20138.","journal-title":"Bowel Dis."},{"issue":"3","key":"1037_CR146","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1093\/ije\/dyu045","volume":"43","author":"MC Harps\u00f8e","year":"2014","unstructured":"Harps\u00f8e MC, Basit S, Andersson M, Nielsen NM, Frisch M, Wohlfahrt J, Nohr EA, Linneberg A, Body T. Body mass index and risk of autoimmune diseases: a study within the Danish National Birth Cohort. Int J Epidemiol. 2014;43(3):843\u201355.","journal-title":"Int J Epidemiol"},{"issue":"5","key":"1037_CR147","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/s41395-018-0031-x","volume":"113","author":"CB Jensen","year":"2018","unstructured":"Jensen CB, \u00c4ngquist LH, Mendall MA, S\u00f8rensen TIA, Baker JL, Jess T, Body T. Childhood body mass index and risk of inflammatory bowel disease in adulthood: a population-based cohort study. Am J Gastroenterol. 2018;113(5):694\u2013701. \nhttps:\/\/doi.org\/10.1038\/s41395-018-0031-x\n\n.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"1037_CR148","doi-asserted-by":"publisher","first-page":"6360","DOI":"10.1038\/s41598-019-42642-8","volume":"9","author":"MA Mendall","year":"2019","unstructured":"Mendall MA, Jensen CB, S\u00f8rensen TIA, \u00c4ngquist LH. Jess TBody mass index in young men and risk of inflammatory bowel disease through adult life: a population-based Danish cohort study. Sci Rep. 2019;9(1):6360. \nhttps:\/\/doi.org\/10.1038\/s41598-019-42642-8\n\n.","journal-title":"Sci Rep."},{"key":"1037_CR149","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/S0140-6736(14)60460-8","volume":"384","author":"M Ng","year":"2014","unstructured":"Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980\u20132013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384:766\u201381.","journal-title":"Lancet"}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-019-01037-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12328-019-01037-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-019-01037-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T23:31:17Z","timestamp":1598311877000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12328-019-01037-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,26]]},"references-count":149,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["1037"],"URL":"https:\/\/doi.org\/10.1007\/s12328-019-01037-y","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"value":"1865-7257","type":"print"},{"value":"1865-7265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,26]]},"assertion":[{"value":"20 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"No potential conflicts of interest. No financial support.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human\/animal rights"}},{"value":"For this retrospective review, formal consent is  not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}